MedX Health Launches SkinSecure™ to Bring Direct, Non-Invasive, Objective Biological Measurement to Skin Health Research

▤ Summary

MedX Health launched SkinSecure™, a cloud-based SaaS platform that connects its imaging devices to CRO and sponsor workflows. The product measures collagen, melanin, dermal melanin, and hemoglobin in a single non-invasive capture and shares results instantly across study sites. The company positions the platform as a replacement for punch biopsies in collagen endpoint studies and as a better way to support dermatology, aesthetics, pharmaceutical, and consumer research. MedX says SkinSecure™ is available immediately, with full commercial deployment starting in July 2026.

▦ Linked Companies

MedX Health

$1M to $5M